A Study to Evaluate the Efficacy and Safety of Gemigliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Dapagliflozin and Metformin (SOLUTION Study)
Clinical trial NCT03842267 · COMPLETED
Trial details
- NCT number
- NCT03842267
- Sponsor
- LG Chem
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-13
- Primary completion
- 2021-05-20
- Enrollment
- 315
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.